All Hong Kong stocks quotes are at least 15 minutes delayed.
02096
SIMCERE PHARMA
HKD
11.6200.150
(1.31%)
1D
High
11.700
Open
11.450
VWAP
11.58
Vol
4.75M
Mkt Cap
35.33B
Low
11.330
Amount
54.96M
EV/EBITDA(TTM)
16.55
Total Shares
2.60B
EV
3.61B
EV/OCF(TTM)
17.79
P/S(TTM)
3.66
Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces various drugs, including Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions. The Company mainly conducts its businesses in the domestic market and overseas markets.
Show More
News
Money Flow
Over the past 66 trading days, overall net money flow is -74.37M, with retail investors contributing -9.36M and major investors adding -42.69M.
Net Buy $ Volume
Net Sell $ Volume
No data
Valuation Metrics
Forward PE
5Y Average PE
19.24
Current PE
19.59
Overvalued PE
25.95
Undervalued PE
12.52
Forward EV/EBITDA
5Y Average EV/EBITDA
13.78
Current EV/EBITDA
14.65
Overvalued EV/EBITDA
18.04
Undervalued EV/EBITDA
9.53
Forward PS
5Y Average PS
2.74
Current PS
3.43
Overvalued PS
3.47
Undervalued PS
2.02
Financials
Al Analysis
Annual
Quarterly
Trading Trends
Daily
Monthly
Buyback
Short Selling
People Also Watch